| Primary |
| Analgesia |
23.5% |
| Spinal Anaesthesia |
12.8% |
| Local Anaesthesia |
10.2% |
| Anaesthesia |
9.2% |
| Musculoskeletal Pain |
7.4% |
| Analgesic Therapy |
5.6% |
| Epidural Anaesthesia |
5.6% |
| Nerve Block |
5.1% |
| General Anaesthesia |
2.3% |
| Pain |
2.3% |
| Product Used For Unknown Indication |
2.0% |
| Prophylaxis |
2.0% |
| Maintenance Of Anaesthesia |
1.8% |
| Surgery |
1.8% |
| Epidural Analgesia |
1.5% |
| Labour Pain |
1.5% |
| Postoperative Analgesia |
1.5% |
| Back Pain |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Premedication |
1.3% |
|
| Musculoskeletal Disorder |
24.9% |
| Musculoskeletal Pain |
23.1% |
| Pain |
5.8% |
| Drug Ineffective |
5.2% |
| Chondrolysis |
4.0% |
| Incorrect Route Of Drug Administration |
4.0% |
| Joint Injury |
4.0% |
| Myoclonus |
2.9% |
| Wrong Drug Administered |
2.9% |
| Wrong Technique In Drug Usage Process |
2.9% |
| Cauda Equina Syndrome |
2.3% |
| Neuromuscular Block Prolonged |
2.3% |
| Neuromuscular Blockade |
2.3% |
| Paraplegia |
2.3% |
| Staphylococcal Infection |
2.3% |
| Cardiac Arrest |
1.7% |
| Circumstance Or Information Capable Of Leading To Medication Error |
1.7% |
| Drug Toxicity |
1.7% |
| Musculoskeletal Discomfort |
1.7% |
| No Therapeutic Response |
1.7% |
|
| Secondary |
| Anaesthesia |
12.6% |
| Product Used For Unknown Indication |
12.0% |
| Pain |
8.8% |
| Epidural Anaesthesia |
8.7% |
| Analgesic Therapy |
8.1% |
| Prophylaxis |
7.0% |
| Spinal Anaesthesia |
6.2% |
| Local Anaesthesia |
4.7% |
| Maternal Exposure During Pregnancy |
4.5% |
| Nerve Block |
3.9% |
| Neuralgia |
3.6% |
| General Anaesthesia |
2.8% |
| Postoperative Analgesia |
2.8% |
| Back Pain |
2.6% |
| Drug Use For Unknown Indication |
2.5% |
| Induction Of Anaesthesia |
2.5% |
| Procedural Pain |
1.9% |
| Foetal Exposure During Pregnancy |
1.7% |
| Anaesthetic Premedication |
1.6% |
| Breakthrough Pain |
1.6% |
|
| Myoclonus |
11.0% |
| Pain |
10.3% |
| Incorrect Route Of Drug Administration |
9.6% |
| Drug Ineffective |
6.6% |
| Maternal Exposure During Pregnancy |
5.9% |
| Drug Exposure During Pregnancy |
5.1% |
| Respiratory Failure |
5.1% |
| Ventricular Fibrillation |
5.1% |
| Respiratory Distress |
4.4% |
| Wrong Drug Administered |
4.4% |
| Maternal Drugs Affecting Foetus |
3.7% |
| Neurotoxicity |
3.7% |
| Paralysis |
3.7% |
| Respiratory Depression |
3.7% |
| Hypoaesthesia |
2.9% |
| Laryngospasm |
2.9% |
| Retinal Vein Occlusion |
2.9% |
| Sedation |
2.9% |
| Sleep Apnoea Syndrome |
2.9% |
| Vomiting |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.9% |
| Muscle Spasticity |
14.5% |
| Pain |
8.9% |
| Drug Use For Unknown Indication |
4.9% |
| Analgesic Therapy |
3.7% |
| Anaesthesia |
2.8% |
| Pain Management |
2.7% |
| Insomnia |
2.4% |
| Induction Of Anaesthesia |
2.1% |
| Local Anaesthesia |
1.6% |
| Prophylaxis |
1.6% |
| Anticoagulant Therapy |
1.2% |
| Cancer Pain |
1.2% |
| Maintenance Of Anaesthesia |
1.2% |
| Acute Myeloid Leukaemia |
1.1% |
| Antiplatelet Therapy |
1.1% |
| Prostate Cancer |
1.1% |
| Toothache |
1.1% |
| Anxiety |
1.0% |
| Rheumatoid Arthritis |
1.0% |
|
| Death |
15.9% |
| Pain |
14.5% |
| Condition Aggravated |
9.0% |
| Withdrawal Syndrome |
6.9% |
| Cholestasis |
5.5% |
| Unresponsive To Stimuli |
4.1% |
| Breast Cancer Metastatic |
3.4% |
| Lung Neoplasm Malignant |
3.4% |
| Nausea |
3.4% |
| Pyrexia |
3.4% |
| Therapeutic Response Decreased |
3.4% |
| Therapy Cessation |
3.4% |
| Vitreous Haemorrhage |
3.4% |
| Vomiting |
3.4% |
| Circulatory Collapse |
2.8% |
| Hypoaesthesia |
2.8% |
| Influenza Like Illness |
2.8% |
| Injury |
2.8% |
| Pancreatitis Chronic |
2.8% |
| Postpartum Haemorrhage |
2.8% |
|
| Interacting |
| Anaesthesia |
23.1% |
| Premedication |
23.1% |
| Thoracic Vertebral Fracture |
15.4% |
| Atrial Fibrillation |
11.5% |
| Pain |
11.5% |
| Hernia Repair |
3.8% |
| Nerve Block |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Sedative Therapy |
3.8% |
|
| Hypotension |
28.6% |
| Cardiac Disorder |
14.3% |
| Drug Interaction |
14.3% |
| Hepatotoxicity |
14.3% |
| Potentiating Drug Interaction |
14.3% |
| Unresponsive To Stimuli |
14.3% |
|
